Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26


Enterococci and Their Interactions with the Intestinal Microbiome.

Dubin K, Pamer EG.

Microbiol Spectr. 2014 Nov;5(6). doi: 10.1128/microbiolspec.BAD-0014-2016.


The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study.

Remschmidt C, Behnke M, Kola A, Peña Diaz LA, Rohde AM, Gastmeier P, Schwab F.

Antimicrob Resist Infect Control. 2017 Sep 13;6:95. doi: 10.1186/s13756-017-0253-5. eCollection 2017.


Receipt of Antibiotics in Hospitalized Patients and Risk for Clostridium difficile Infection in Subsequent Patients Who Occupy the Same Bed.

Freedberg DE, Salmasian H, Cohen B, Abrams JA, Larson EL.

JAMA Intern Med. 2016 Dec 1;176(12):1801-1808. doi: 10.1001/jamainternmed.2016.6193.


Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults.

Monteserin N, Larson E.

J Hosp Infect. 2016 Nov;94(3):236-241. doi: 10.1016/j.jhin.2016.07.023. Epub 2016 Aug 24.


Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University Hospitals intensive care units, Egypt.

Moemen D, Tawfeek D, Badawy W.

Braz J Microbiol. 2015 Jul 1;46(3):777-83. doi: 10.1590/S1517-838246320140403. eCollection 2015 Jul-Sep.


Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management.

O'Driscoll T, Crank CW.

Infect Drug Resist. 2015 Jul 24;8:217-30. doi: 10.2147/IDR.S54125. eCollection 2015. Review.


Case-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.

Cheah AL, Peel T, Howden BP, Spelman D, Grayson ML, Nation RL, Kong DC.

BMC Infect Dis. 2014 Jun 28;14:353. doi: 10.1186/1471-2334-14-353.


Confounding by indication affects antimicrobial risk factors for methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition.

Datta R, Kleinman K, Rifas-Shiman S, Placzek H, Lankiewicz J, Platt R, Huang SS.

Antimicrob Resist Infect Control. 2014 Jun 1;3:19. doi: 10.1186/2047-2994-3-19. eCollection 2014.


Algorithm for pre-emptive glycopeptide treatment in patients with haematologic malignancies and an Enterococcus faecium bloodstream infection.

Zhou X, Arends JP, Span LF, Friedrich AW.

Antimicrob Resist Infect Control. 2013 Sep 11;2(1):24. doi: 10.1186/2047-2994-2-24.


Antimicrobial susceptibility pattern and epidemiology of female urinary tract infections in South Korea, 2010-2011.

Lee DS, Choe HS, Lee SJ, Bae WJ, Cho HJ, Yoon BI, Cho YH, Han CH, Jang H, Park SB, Cho WJ, Lee SJ.

Antimicrob Agents Chemother. 2013 Nov;57(11):5384-93. doi: 10.1128/AAC.00065-13. Epub 2013 Aug 19.


Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Schechner V, Temkin E, Harbarth S, Carmeli Y, Schwaber MJ.

Clin Microbiol Rev. 2013 Apr;26(2):289-307. doi: 10.1128/CMR.00001-13. Review.


Communication interventions to improve adherence to infection control precautions: a randomised crossover trial.

Ong MS, Magrabi F, Post J, Morris S, Westbrook J, Wobcke W, Calcroft R, Coiera E.

BMC Infect Dis. 2013 Feb 6;13:72. doi: 10.1186/1471-2334-13-72.


Do contact precautions cause depression? A two-year study at a tertiary care medical centre.

Day HR, Perencevich EN, Harris AD, Himelhoch SS, Brown CH, Gruber-Baldini AL, Dotter E, Morgan DJ.

J Hosp Infect. 2011 Oct;79(2):103-7. doi: 10.1016/j.jhin.2011.03.026. Epub 2011 Jun 12.


De novo daptomycin nonsusceptibility in a clinical isolate.

Lesho EP, Wortmann GW, Craft D, Moran KA.

J Clin Microbiol. 2006 Feb;44(2):673. No abstract available.


Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures.

Padiglione AA, Wolfe R, Grabsch EA, Olden D, Pearson S, Franklin C, Spelman D, Mayall B, Johnson PD, Grayson ML.

Antimicrob Agents Chemother. 2003 Aug;47(8):2492-8.


Supplemental Content

Support Center